On Sep 8, 2021 A-Alpha Bio closed a Series A round and raised $20,000,000 from Lux Capital, Madrona Venture Group, Perceptive Advisors, featuring lead investors […]
Post-IPO Equity – Biostage
On Sep 8, 2021 Biostage closed a Post-IPO Equity round and raised $2,600,000 from investors, featuring lead investors . About the company: Biostage is located […]
Funding Round – Altoida, Inc.
On Sep 8, 2021 Altoida, Inc. closed a Funding Round round and raised $498,335 from Alzheimer’s Drug Discovery Foundation, featuring lead investors Alzheimer’s Drug Discovery […]
Series E – Emulate
On Sep 7, 2021 Emulate closed a Series E round and raised $82,000,000 from Northpond Ventures, Perceptive Advisors, featuring lead investors Northpond Ventures. About the […]
Seed Round – Seqera Labs
On Sep 7, 2021 Seqera Labs closed a Seed round and raised $5,500,000 from BoxOne Ventures, Speedinvest, Talis Capital, featuring lead investors Speedinvest, Talis Capital. […]
Series A – Via Nova Therapeutics
On Sep 7, 2021 Via Nova Therapeutics closed a Series A round and raised $20,000,000 from Aditum Bio, featuring lead investors Aditum Bio. About the […]
Series A – EnteroBiotix
On Sep 7, 2021 EnteroBiotix closed a Series A round and raised £15,500,000 from Kineticos Ventures, Scottish Enterprise, SIS Ventures, Thairm Bio, featuring lead investors […]
Post-IPO Equity – Adaptimmune
On Sep 7, 2021 Adaptimmune closed a Post-IPO Equity round and raised $150,000,000 from Genentech, featuring lead investors Genentech. About the company: Adaptimmune is located […]
Grant – Community Health Network of North Central Massachusetts
On Sep 7, 2021 Community Health Network of North Central Massachusetts closed a Grant round and raised $200,000 from UMass Memorial Health Care, featuring lead […]
Series E – Emulate
On Sep 7, 2021 Emulate closed a Series E round and raised $82,000,000 from Northpond Ventures, Perceptive Advisors, featuring lead investors Northpond Ventures. About the […]
